Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022005961 - PRPK INHIBITORS

Publication Number WO/2022/005961
Publication Date 06.01.2022
International Application No. PCT/US2021/039358
International Filing Date 28.06.2021
IPC
A61K 38/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
06Tripeptides
A61K 39/395 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Applicants
  • DANA-FARBER CANCER INSTITUTE, INC. [US]/[US]
Inventors
  • ANDERSON, Kenneth C.
  • HIDESHIMA, Teru
  • DHE-PAGANON, Sirano
  • SEO, Hyuk-Soo
  • MIZUTANI, Takashi
  • ZHANG, Tinghu
Agents
  • ZHANG, Tony
  • BOYLE, Craig D.
Priority Data
63/045,74529.06.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PRPK INHIBITORS
(FR) INHIBITEURS DE PRPK
Abstract
(EN) This disclosure relates to compounds of formula (I) as defined in the Specification. This disclosure also relates to methods of synthesizing the compound of formula (I) and using the compounds of formula (I) for treating a disease (e.g., cancer).
(FR) La présente invention concerne des composés de formule (I) tels que définis dans la description. La présente invention concerne également des procédés de synthèse des composés de formule (I) et l'utilisation des composés de formule (I) pour le traitement d'une maladie (par exemple le cancer).
Latest bibliographic data on file with the International Bureau